1. Association of coronary inflammation with plaque vulnerability and fractional flow reserve in coronary artery disease.
- Author
-
Choi YJ, Yang S, West H, Tomlins P, Hoshino M, Murai T, Hwang D, Shin ES, Doh JH, Nam CW, Wang J, Matsuo H, Kakuta T, Antoniades C, and Koo BK
- Abstract
Background: The fat attenuation index (FAI) measured using coronary computed tomography angiography (CCTA) enables the direct evaluation of pericoronary adipose tissue composition and vascular inflammation. We aimed to investigate the association of fractional flow reserve (FFR) and plaque vulnerability with coronary inflammation., Methods: Patients with suspected coronary artery disease (CAD) who underwent CCTA and invasive FFR measurements within 90-day were included. A cloud-based medical device, CaRi-Heart, serves as a surrogate tool for evaluating coronary inflammation based on FAI by analyzing CCTA images. The correlations between CCTA-defined plaque characteristics, invasive coronary angiographic and physiologic assessments, and CaRi-Heart risk were analyzed. The primary endpoint was the patient-oriented composite outcome (POCO) consisting of all-cause death, any myocardial infarction, and any revascularization., Results: A total of 564 patients (median age 67.0 years; 75.4 % men) were included. There were no significant differences in quantitative and qualitative plaque characteristics or FFR between the high- and low-CaRi-Heart risk groups (i.e., ≥5 % and <5 %). During the median follow-up of 3.2 years [1.13-4.73 years], CaRi-Heart risk ≥5 % was associated with a significantly higher rate of POCO compared to CaRi-Heart risk <5 % (0.9 % vs. 10.1 %, P = 0.037). The CaRi-Heart risk was an independent predictor of POCO as a continuous (adjusted HR 1.016, 95 % CI 1.005-0.027, P = 0.004) and categorical variable (CaRi-Heart risk ≥5 %, adjusted HR 2.949, 95 % CI 1.182-7.360, P = 0.021), regardless of high-risk plaque characteristics and FFR., Conclusion: Coronary inflammation risk assessed using CaRi-Heart risk provides independent prognostic information regardless of plaque vulnerability and physiologic stenosis in patients with CAD., Competing Interests: Declaration of competing interest Dr Bon-Kwon Koo received an Institutional Research Grant from Abbott Vascular and Philips Volcano. Dr. Joon Hyung Doh received a Research Grant from Philips Volcano. All other authors declare that there is no conflict of interest relevant to the submitted work. Dr Tomlins is an employee of Caristo Diagnostics Ltd. Dr Antoniades is a founder, shareholder, and director of Caristo Diagnostics Ltd, a CT-image analysis company., (Copyright © 2024 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF